Skip to main content

Peer Review reports

From: Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study

Original Submission
2 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
24 Apr 2022 Reviewed Reviewer Report - Emre Yekedüz
25 Apr 2022 Reviewed Reviewer Report - Meryem Aktan
17 May 2022 Reviewed Reviewer Report - Saadettin Kilickap
21 May 2022 Author responded Author comments - Han-Ping Shi
Resubmission - Version 5
21 May 2022 Submitted Manuscript version 5
28 May 2022 Author responded Author comments - Han-Ping Shi
Resubmission - Version 6
28 May 2022 Submitted Manuscript version 6
30 May 2022 Author responded Author comments - Han-Ping Shi
Resubmission - Version 7
30 May 2022 Submitted Manuscript version 7
6 Jun 2022 Reviewed Reviewer Report - Emre Yekedüz
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
7 Jun 2022 Editorially accepted
25 Jun 2022 Article published 10.1186/s12885-022-09752-5

You can find further information about peer review here.

Back to article page